“…Of special interest is a large group of measures that are based on the concept of information entropy ( Bandt & Pompe, 2002 ; Costa et al, 2002 , 2005 ; Courtiol et al, 2016 ; Dávalos et al, 2019 ; Fadlallah et al, 2013 ; Inouye et al, 1991 ; Keshmiri, 2020 ; Kosciessa et al, 2020 ; Richman & Moorman, 2000 ; Y. Yin et al, 2016 ). Entropy measures have been helpful in psychophysiological studies of healthy subjects ( Fekete et al, 2021 ; Grady & Garrett, 2018 ; M. Liu et al, 2019 ; Mahjoory et al, 2019 ; Miskovic et al, 2019 ; Waschke et al, 2019 ), and growing evidence suggests that the measures can also be used to demonstrate a significant, progressive loss of entropy of neural activity in AD patients ( Ando et al, 2021 ; Echegoyen et al, 2020 ; Gómez & Hornero, 2010 ; Maturana-Candelas et al, 2019 ; Shumbayawonda et al, 2020 ; Su et al, 2021 ; W. Y. Yu et al, 2021 ). This suggests that measures of complexity or entropy could have potential as biomarkers for AD.…”